The American Chemistry Council (ACC), the main trade body of the chemicals industry in the US, has issued a ‘9 in 9 Challenge’ to Congress and the Environmental Protection Agency (EPA). These challenges arise from the revision of the Toxic Substances Control Act (TSCA) in 2016.
Following three years of investigations into the uses of and risks posed to human health and the environment by polyfluoroalkyl substances (PFASs), the national authorities of Denmark, Germany, the Netherlands, Norway and Sweden have concluded that these risks are not adequately controlled.
Czech Republic-based J&T MS 1 SICAV has sent a public letter to the board of TiO2 producer Venator Materials highly critical of the firm’s strategic direction and demanding additional independent shareholder representation.
A subsidiary of Indian speciality chemicals company Dorf Ketal has acquired Fluid Energy Group’s global modified and synthetic acid business, including the Triton industrial business.
The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.
UK-based CDMO Sterling Pharma Solutions has completed the acquisition of Novartis’ API facility in Ringaskiddy, near Cork, Ireland. The deal includes an on-going supply agreement to make APIs for cardiovascular, immunology and oncology medicines for Novartis.
Heraeus Precious Metals and Sweden’s Hulteberg have agreed on a strategic partnership to jointly develop and commercialize a variety of catalysts that are required for the operation of solid oxide fuel cells (SOFCs).
Current Issue
CordenPharma has signed a multi-year agreement for the contract manufacture of a large-volume launch peptid
In response to an increasing number of projects, notably in oncology, Indian CRDMO Sai Life Sciences, has o
The American Chemistry Council (ACC), the main trade body of the chemicals industry in the US, has issued a
Following three years of investigations into the uses of and risks posed to human health and the environmen
Most Popular
Pharmaceutical CDMOs are continuing to invest in a buoyant market. We report from CPHI Frankfurt
The mood among CDMOs remained buoyant at the rebranded CPHI Frankfurt show, which took place on 1-3 November. There were several announcements of major investments and most of the exhibitors SCM spoke to were optimistic about continued rapid growth, particularly in new modalities of all kinds.
Czech Republic-based J&T MS 1 SICAV has sent a public letter to the board of TiO2 producer Venator Materials highly critical of the firm’s strategic direction and demanding additional independent shareholder representation. J&T is the second largest shareholder in Venator, with a stake of 14.3%.
Since an IPO in August 2017, the letter states, Venator’s share price has fallen by about 96% from a peak of $25.50 to less than $1. In November 2022, the company was warned that it faces a potential delisting from the New York Stock Exchange.
The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland. Eight new chemical reactors and a new packaging plant were commissioned in September, largely as a result of a long-term supply contract with a new customer from the crop protection industry. Further ‘double-digit millions’ investments are currently being made or in the pipeline.
